176 related articles for article (PubMed ID: 17072810)
1. [Cannabinoid system and neuroinflammation:therapeutic perspectives in multiple sclerosis].
Mestre L; Correa F; Docagne F; Clemente D; Ortega-Gutiérrez S; Arévalo-Martín A; Molina-Holgado E; Borrell J; Guaza C
Rev Neurol; 2006 Nov 1-15; 43(9):541-8. PubMed ID: 17072810
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid system and neuroinflammation: implications for multiple sclerosis.
Correa F; Docagne F; Mestre L; Loría F; Hernangómez M; Borrell J; Guaza C
Neuroimmunomodulation; 2007; 14(3-4):182-7. PubMed ID: 18073512
[TBL] [Abstract][Full Text] [Related]
3. Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide.
Loría F; Petrosino S; Mestre L; Spagnolo A; Correa F; Hernangómez M; Guaza C; Di Marzo V; Docagne F
Eur J Neurosci; 2008 Aug; 28(4):633-41. PubMed ID: 18657182
[TBL] [Abstract][Full Text] [Related]
4. The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis.
Rossi S; Bernardi G; Centonze D
Exp Neurol; 2010 Jul; 224(1):92-102. PubMed ID: 20353778
[TBL] [Abstract][Full Text] [Related]
5. The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis.
Centonze D; Rossi S; Finazzi-Agrò A; Bernardi G; Maccarrone M
Int Rev Neurobiol; 2007; 82():171-86. PubMed ID: 17678961
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective agents: cannabinoids.
Sánchez AJ; García-Merino A
Clin Immunol; 2012 Jan; 142(1):57-67. PubMed ID: 21420365
[TBL] [Abstract][Full Text] [Related]
7. [The role of endocannabinoid system in physiological and pathological processes in the eye].
Nadolska K; Goś R
Klin Oczna; 2008; 110(10-12):392-6. PubMed ID: 19195174
[TBL] [Abstract][Full Text] [Related]
8. New insights into adaptive immunity in chronic neuroinflammation.
Siffrin V; Brandt AU; Herz J; Zipp F
Adv Immunol; 2007; 96():1-40. PubMed ID: 17981203
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?
Oesch S; Gertsch J
J Pharm Pharmacol; 2009 Jul; 61(7):839-53. PubMed ID: 19589225
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid signaling in glial cells.
Stella N
Glia; 2004 Dec; 48(4):267-77. PubMed ID: 15390110
[TBL] [Abstract][Full Text] [Related]
11. Acute and chronic cannabinoid extracts administration affects motor function in a CREAE model of multiple sclerosis.
Buccellato E; Carretta D; Utan A; Cavina C; Speroni E; Grassi G; Candeletti S; Romualdi P
J Ethnopharmacol; 2011 Feb; 133(3):1033-8. PubMed ID: 21094240
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoids and the immune system: an overview.
Tanasescu R; Constantinescu CS
Immunobiology; 2010 Aug; 215(8):588-97. PubMed ID: 20153077
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids as potential anti-epileptic drugs.
Smith PF
Curr Opin Investig Drugs; 2005 Jul; 6(7):680-5. PubMed ID: 16044663
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid receptors: where they are and what they do.
Mackie K
J Neuroendocrinol; 2008 May; 20 Suppl 1():10-4. PubMed ID: 18426493
[TBL] [Abstract][Full Text] [Related]
15. Multiple roles for the endocannabinoid system during the earliest stages of life: pre- and postnatal development.
Fride E
J Neuroendocrinol; 2008 May; 20 Suppl 1():75-81. PubMed ID: 18426504
[TBL] [Abstract][Full Text] [Related]
16. [The modulatory role of endocannabinoids in sleep].
Murillo-Rodríguez E
Rev Neurol; 2008 Feb 1-15; 46(3):160-6. PubMed ID: 18297624
[TBL] [Abstract][Full Text] [Related]
17. [The cannabinoid system and pain: a new therapeutic avenue?].
Desroches J; Beaulieu P
Rev Med Suisse; 2008 Jun; 4(162):1505-6, 1508-10, 1512-3. PubMed ID: 18649597
[TBL] [Abstract][Full Text] [Related]
18. The endocannabinoid system in targeting inflammatory neurodegenerative diseases.
Centonze D; Finazzi-Agrò A; Bernardi G; Maccarrone M
Trends Pharmacol Sci; 2007 Apr; 28(4):180-7. PubMed ID: 17350694
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?
Croxford JL; Yamamura T
J Neuroimmunol; 2005 Sep; 166(1-2):3-18. PubMed ID: 16023222
[TBL] [Abstract][Full Text] [Related]
20. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
Ligresti A; Petrosino S; Di Marzo V
Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
